These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 18671316)

  • 1. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
    Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
    J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.
    Kucerova L; Skolekova S; Demkova L; Bohovic R; Matuskova M
    Gene Ther; 2014 Oct; 21(10):874-87. PubMed ID: 25056607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene.
    Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR
    Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.
    Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L
    J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine.
    Kucerova L; Matuskova M; Hlubinova K; Bohovic R; Feketeova L; Janega P; Babal P; Poturnajova M
    Cancer Lett; 2011 Dec; 311(1):101-12. PubMed ID: 21824724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.
    Matuskova M; Hlubinova K; Pastorakova A; Hunakova L; Altanerova V; Altaner C; Kucerova L
    Cancer Lett; 2010 Apr; 290(1):58-67. PubMed ID: 19765892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
    Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
    Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclasts direct bystander killing of cancer cells in vitro.
    Ramnaraine M; Pan W; Clohisy DR
    Bone; 2006 Jan; 38(1):4-12. PubMed ID: 16139579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
    Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma.
    Yi C; Huang Y; Guo ZY; Wang SR
    Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy.
    Kucerova L; Altanerova V; Matuskova M; Tyciakova S; Altaner C
    Cancer Res; 2007 Jul; 67(13):6304-13. PubMed ID: 17616689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
    Erbs P; Regulier E; Kintz J; Leroy P; Poitevin Y; Exinger F; Jund R; Mehtali M
    Cancer Res; 2000 Jul; 60(14):3813-22. PubMed ID: 10919655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
    Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
    Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.
    Abrate A; Buono R; Canu T; Esposito A; Del Maschio A; Lucianò R; Bettiga A; Colciago G; Guazzoni G; Benigni F; Hedlund P; Altaner C; Montorsi F; Cavarretta IT
    Eur J Cancer; 2014 Sep; 50(14):2478-88. PubMed ID: 25060826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.